Search all trials

Find therapies in clinical trials near you – page 28

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Escherichia urinary tract infection

Not recruiting

Investigational

Study of ExPEC9V vaccine for preventing invasive E.

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Ecoo15

Contact Research Centre

Chronic inflammatory demyelinating polyradiculoneuropathy

Not recruiting

Investigational

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Riliprubart

Contact Research Centre

Clear cell papillary renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Eosinophilic oesophagitis

Not recruiting

Registered drug

Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

Registered drug

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tezepelumab

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo

Czechia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deutivacaftor

Contact Research Centre

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Not recruiting

Registered drug

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Dextrose Bp

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

Registered drugNo placebo

Czechia

Participants:18–64 years
Substances:Bortezomib

Contact Research Centre

Cardiac failure chronic

Not recruiting

Investigational

Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:Azd5462

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Paroxysmal nocturnal haemoglobinuria

Not recruiting

Registered drugNo placebo

Study on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Danicopan

Contact Research Centre

Short-bowel syndrome

Not recruiting

InvestigationalNo placebo

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Apraglutide

Contact Research Centre

Find therapies in clinical trials near you – page 28

390 trials match your criteria

Escherichia urinary tract infection

Study of ExPEC9V vaccine for preventing invasive E.

Chronic inflammatory demyelinating polyradiculoneuropathy

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Clear cell papillary renal cell carcinoma

Study Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma

Chronic myeloid leukaemia

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Eosinophilic oesophagitis

Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

Cystic fibrosis

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Study of Durvalumab and Tremelimumab for Patients with Limited Stage Small-Cell Lung Cancer After Chemoradiation Therapy

Plasma cell myeloma

Study Comparing Daratumumab with Drug Combination for Young Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplantation

Cardiac failure chronic

Study on the Effects of AZD5462 for Patients with Stable Chronic Heart Failure

Plasma cell myeloma refractory

Study Comparing Teclistamab with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma After 1-3 Prior Treatments

Paroxysmal nocturnal haemoglobinuria

Study on the Long-term Safety and Effectiveness of Danicopan with Ravulizumab or Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Short-bowel syndrome

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.